Vectormune ND

Country: European Union

Language: Slovak

Source: EMA (European Medicines Agency)

Buy It Now

Active ingredient:

bunkový rekombinantný herpes vírus (rHVT / ND) asociovaný s bunkami, ktorý exprimuje fúzny proteín vírusu newcastle disease D-26 lentogénneho kmeňa

Available from:

CEVA-Phylaxia Co. Ltd.

ATC code:

QI01AD

INN (International Name):

Newcastle disease and Marek’s disease vaccine (live recombinant)

Therapeutic group:

Chicken; Embryonated eggs

Therapeutic area:

Immunologicals pre aves, Živé vírusové vakcíny

Therapeutic indications:

Pre aktívnej imunizácie z 18. deň-staré embryonated slepačie vajcia alebo one-day-old chicks na zníženie úmrtnosti a klinické príznaky spôsobené vírus vtáčej chrípky a znížiť úmrtnosť, klinické príznaky a lézie spôsobené Marek choroba vírus s fenotyp "virulentné".

Product summary:

Revision: 7

Authorization status:

oprávnený

Authorization date:

2015-09-08

Patient Information leaflet

                                OFFICIAL ADDRESS
Domenico Scarlattilaan 6
●
1083 HS Amsterdam
●
The Netherlands
An agency of the European Union
ADDRESS FOR VISITS AND DELIVERIES
Refer to www.ema.europa.eu/how-to-find-us
SEND US A QUESTION
Go to
www.ema.europa.eu/contact
TELEPHONE
+31 (0)88 781
6000
© European Medicines Agency,
2023. Reproduction is authorised provided the source is acknowledged.
Aktuálne informácie o tomto veterinárnom lieku sa nachádzajú na
webovom sídle, kde sú
uverejnené informácie o veterinárnych liekoch.
                                
                                Read the complete document
                                
                            

Summary of Product characteristics

                                OFFICIAL ADDRESS
Domenico Scarlattilaan 6
●
1083 HS Amsterdam
●
The Netherlands
An agency of the European Union
ADDRESS FOR VISITS AND DELIVERIES
Refer to www.ema.europa.eu/how-to-find-us
SEND US A QUESTION
Go to
www.ema.europa.eu/contact
TELEPHONE
+31 (0)88 781
6000
© European Medicines Agency,
2023. Reproduction is authorised provided the source is acknowledged.
Aktuálne informácie o tomto veterinárnom lieku sa nachádzajú na
webovom sídle, kde sú
uverejnené informácie o veterinárnych liekoch.
                                
                                Read the complete document
                                
                            

Documents in other languages

Patient Information leaflet Patient Information leaflet Bulgarian 15-02-2024
Summary of Product characteristics Summary of Product characteristics Bulgarian 15-02-2024
Public Assessment Report Public Assessment Report Bulgarian 10-04-2018
Patient Information leaflet Patient Information leaflet Spanish 15-02-2024
Public Assessment Report Public Assessment Report Spanish 10-04-2018
Patient Information leaflet Patient Information leaflet Czech 15-02-2024
Public Assessment Report Public Assessment Report Czech 10-04-2018
Patient Information leaflet Patient Information leaflet Danish 15-02-2024
Public Assessment Report Public Assessment Report Danish 10-04-2018
Patient Information leaflet Patient Information leaflet German 15-02-2024
Public Assessment Report Public Assessment Report German 10-04-2018
Patient Information leaflet Patient Information leaflet Estonian 15-02-2024
Public Assessment Report Public Assessment Report Estonian 10-04-2018
Patient Information leaflet Patient Information leaflet Greek 15-02-2024
Public Assessment Report Public Assessment Report Greek 10-04-2018
Patient Information leaflet Patient Information leaflet English 15-02-2024
Public Assessment Report Public Assessment Report English 10-04-2018
Patient Information leaflet Patient Information leaflet French 15-02-2024
Public Assessment Report Public Assessment Report French 10-04-2018
Patient Information leaflet Patient Information leaflet Italian 15-02-2024
Public Assessment Report Public Assessment Report Italian 10-04-2018
Patient Information leaflet Patient Information leaflet Latvian 15-02-2024
Public Assessment Report Public Assessment Report Latvian 10-04-2018
Patient Information leaflet Patient Information leaflet Lithuanian 15-02-2024
Summary of Product characteristics Summary of Product characteristics Lithuanian 15-02-2024
Public Assessment Report Public Assessment Report Lithuanian 10-04-2018
Patient Information leaflet Patient Information leaflet Hungarian 15-02-2024
Summary of Product characteristics Summary of Product characteristics Hungarian 15-02-2024
Public Assessment Report Public Assessment Report Hungarian 10-04-2018
Patient Information leaflet Patient Information leaflet Maltese 15-02-2024
Public Assessment Report Public Assessment Report Maltese 10-04-2018
Patient Information leaflet Patient Information leaflet Dutch 15-02-2024
Public Assessment Report Public Assessment Report Dutch 10-04-2018
Patient Information leaflet Patient Information leaflet Polish 15-02-2024
Public Assessment Report Public Assessment Report Polish 10-04-2018
Patient Information leaflet Patient Information leaflet Portuguese 15-02-2024
Summary of Product characteristics Summary of Product characteristics Portuguese 15-02-2024
Public Assessment Report Public Assessment Report Portuguese 10-04-2018
Patient Information leaflet Patient Information leaflet Romanian 15-02-2024
Public Assessment Report Public Assessment Report Romanian 10-04-2018
Patient Information leaflet Patient Information leaflet Slovenian 15-02-2024
Summary of Product characteristics Summary of Product characteristics Slovenian 15-02-2024
Public Assessment Report Public Assessment Report Slovenian 10-04-2018
Patient Information leaflet Patient Information leaflet Finnish 15-02-2024
Public Assessment Report Public Assessment Report Finnish 10-04-2018
Patient Information leaflet Patient Information leaflet Swedish 15-02-2024
Public Assessment Report Public Assessment Report Swedish 10-04-2018
Patient Information leaflet Patient Information leaflet Norwegian 15-02-2024
Summary of Product characteristics Summary of Product characteristics Norwegian 15-02-2024
Patient Information leaflet Patient Information leaflet Icelandic 15-02-2024
Summary of Product characteristics Summary of Product characteristics Icelandic 15-02-2024
Patient Information leaflet Patient Information leaflet Croatian 15-02-2024
Public Assessment Report Public Assessment Report Croatian 10-04-2018

View documents history